Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023

Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023

Introduction: influenza is an acute viral disease caused by infection of the upper respiratory tract - difficult to control, which affects a large part of the population. Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the antiviral drugs utilized in Romania for the treatment...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Mihai Maria Elena, Ivanciuc Alina Elena, Cherciu Carmen Maria, Mihăescu Grigore, Lazăr Mihaela
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Sciendo 2024-04-01
Reeks:	Romanian Journal of Laboratory Medicine
Onderwerpen:	influenza virus neuraminidase phenotypic method antivirals
Online toegang:	https://doi.org/10.2478/rrlm-2024-0010

Gelijkaardige items

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
door: Chiara Medaglia, et al.
Gepubliceerd in: (2021-06-01)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
door: Zhichao Xu, et al.
Gepubliceerd in: (2022-06-01)

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
door: Mira C. Patel, et al.
Gepubliceerd in: (2024-07-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
door: Hwajung Yi, et al.
Gepubliceerd in: (2010-12-01)

Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
door: Amytis Gholami, et al.
Gepubliceerd in: (2022-08-01)

Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication
door: Jackelyn Murray, et al.
Gepubliceerd in: (2023-11-01)

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
door: Yaqin Bai, et al.
Gepubliceerd in: (2021-04-01)

Clinical Implications of Antiviral Resistance in Influenza
door: Timothy C. M. Li, et al.
Gepubliceerd in: (2015-09-01)

nucleoside analogues for the treatment of influenza: history and experience
door: K. V. Kasianenko, et al.
Gepubliceerd in: (2019-10-01)

Synthesis and Biological Evaluation of <i>NH</i><sub>2</sub>-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
door: Yaping Hu, et al.
Gepubliceerd in: (2019-06-01)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
door: Margaret Okomo-Adhiambo, et al.
Gepubliceerd in: (2015-01-01)

Non-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals―Systematic Review
door: Luis Márquez-Domínguez, et al.
Gepubliceerd in: (2024-06-01)

INFLUENZA. DIAGNOSTICS, STRATEGY FOR SELECTION OF ANTI-VIRALS
door: N. V. Orlova
Gepubliceerd in: (2018-01-01)

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
door: Li Y, et al.
Gepubliceerd in: (2017-08-01)

Influenza antivirals and animal models
door: C. Joaquin Caceres, et al.
Gepubliceerd in: (2022-06-01)

Combination Chemotherapy for Influenza
door: Robert G. Webster, et al.
Gepubliceerd in: (2010-07-01)

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies
door: Natalia A. Ilyushina, et al.
Gepubliceerd in: (2019-11-01)

The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu®): A Challenge for Synthesis & Process Research
door: Stefan Abrecht, et al.
Gepubliceerd in: (2004-09-01)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
door: Madhusudan Rajendran, et al.
Gepubliceerd in: (2017-05-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
door: Parvaiz A Koul, et al.
Gepubliceerd in: (2024-01-01)

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
door: Sphamadla E. Mtambo, et al.
Gepubliceerd in: (2021-02-01)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
door: Makoto Ujike, et al.
Gepubliceerd in: (2010-06-01)

Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses
door: Ye Wang, et al.
Gepubliceerd in: (2018-09-01)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
door: Renee W. Y. Chan, et al.
Gepubliceerd in: (2022-02-01)

A Novel Series of Sialic Acid-Based Influenza Virus Inhibitors that Target Influenza Virus Neuraminidase
door: Mark von Itzstein
Gepubliceerd in: (2019-08-01)

Discovery of Novel Boron-Containing <em>N</em>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
door: Ruifang Jia, et al.
Gepubliceerd in: (2022-09-01)

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
door: Luca T. Giurgea, et al.
Gepubliceerd in: (2020-07-01)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
door: Makoto Ujike, et al.
Gepubliceerd in: (2011-03-01)

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
door: Madhusudan Rajendran, et al.
Gepubliceerd in: (2021-08-01)

Antiviral activity of Chongkukjang extracts against influenza A virus in vitro and in vivo
door: Bai Wei, et al.
Gepubliceerd in: (2015-06-01)

PCR for Detection of Oseltamivir Resistance Mutation in Influenza A(H7N9) Virus
door: Wei Wang, et al.
Gepubliceerd in: (2014-05-01)

Drugs for Influenza Treatment: Is There Significant News?
door: Nicola Principi, et al.
Gepubliceerd in: (2019-05-01)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
door: Aeron C. Hurt, et al.
Gepubliceerd in: (2016-06-01)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
door: Jiwei Zhang, et al.
Gepubliceerd in: (2023-12-01)

Specific Influenza Therapy: Current State and Prospects (Review)
door: A. I. Odnovorov, et al.
Gepubliceerd in: (2020-02-01)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
door: Rebekah Honce, et al.
Gepubliceerd in: (2023-08-01)

Impact of Oseltamivir and Diabetes Development
door: Bor-Show Tzang, et al.
Gepubliceerd in: (2025-01-01)

Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase
door: Yanni Lai, et al.
Gepubliceerd in: (2021-04-01)

Study of Antibodies to Influenza Neuraminidase N2
door: Yulia Desheva, et al.
Gepubliceerd in: (2022-04-01)

Exploring the chemical space of influenza neuraminidase inhibitors
door: Nuttapat Anuwongcharoen, et al.
Gepubliceerd in: (2016-04-01)